Loading...
Loading...
Among the 4 tracked institutional investors we monitor, IGC (IGC PHARMA INC) is held with a combined value of $688.14K across 2,537,840 shares. The largest holder is VANGUARD GROUP INC with a position worth $322.94K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund reduced its position.
Total Institutional Value
$688.14K
Total Shares Held
2,537,840
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $322.94K | 0.00% | New |
| 2 | BlackRock, Inc. | $185.10K | 0.00% | - |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $127.28K | 0.00% | -47.4% |
| 4 | STATE STREET CORP | $52.81K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of IGC with a position worth $322.94K, representing 0.00% of their portfolio. In total, 4 institutional investors hold IGC with a combined value of $688.14K.
In the most recent quarter, 1 fund opened a new position in IGC. Additionally, 1 reduced their positions.
Institutional investors hold $688.14K worth of IGC stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $322.94K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For IGC, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their IGC positions.